CHLORPHENIRAMINE MALEATE
-
chlorpheniramine maleate tablet
UDL Laboratories Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Ask a doctor before use if you have
In case of overdose, get medical help or contact a Poison Control Center right away.
adults and children 12 years of age and over | 1 tablet every 4 to 6 hours. Do not take more than 6 tablets in 24 hours. |
children 6 to under 12 years of age |
1/2 tablet (break tablet in half) every 4 to 6 hours. |
children under 6 years of age | do not use this product in children under 6 years of age |
anhydrous lactose, corn starch, D&C yellow #10 aluminum lake, magnesium stearate, microcrystalline cellulose
1-800-848-0462
Chlorpheniramine Maleate Tablets are available as follows:
4 mg - Round, convex, yellow tablets bisected and imprinted with 44 over 194 on one side.
NDC 51079-163-20 - Unit dose blister packages of 100 (10 cards of 10 tablets each).
Manufactured by:
LNK International, Inc.
Hauppauge, NY 11788
Distributed by:
UDL Laboratories, Inc.
Rockford, IL 61103
S-5563 R9
6/10
NDC 51079-163-20
CHLORPHENIRAMINE
MALEATE
TABLETS
4 mg
Antihistamine
100 Tablets (10 x 10)
Protect from excessive moisture.
TAMPER EVIDENT: DO NOT USE IF BLISTER
UNITS ARE TORN, BROKEN OR
SHOW ANY SIGNS OF TAMPERING.
Manufactured by:
LNK International, Inc.
Hauppauge, NY 11788
S-5562 R12
Packaged and Distributed by:
UDL LABORATORIES, INC.
ROCKFORD, IL 61103
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.
CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part341 | 06/14/2011 |
Labeler - UDL Laboratories Inc. (039615992) |
Revised: 06/2010 UDL Laboratories Inc.